Latest Amgen Stories
Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif., Nov.
CHICAGO, Oct. 31, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.
Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) MONROVIA, Calif., Oct. 28, 2014 /PRNewswire/ -- Xencor, Inc.
Plans to Payout Approximately 60 Percent of Adjusted Net Income on Average to Shareholders Through 2018 NEW YORK, Oct.
THOUSAND OAKS, Calif., Oct. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will hold its Business Review Meeting on Tuesday, Oct.
THOUSAND OAKS, Calif., Oct.
RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store.
A California man filed a class action lawsuit against Immunex and Caremark CVS alleging that the pharmacy fails to properly refrigerate best-selling drug Enbrel when filling a mail order Caremark
THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of R.
THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directors today declared a $0.61 per share dividend for the fourth quarter of 2014.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.